We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRL icon
651
Hormel Foods
HRL
$14.2B
$1.12M 0.01%
24,623
+2,453
+11% +$114K
LICY
652
DELISTED
Li-Cycle Holdings Corp.
LICY
$1.11M 0.01%
29,250
– –
HWM icon
653
Howmet Aerospace
HWM
$109B
$1.1M 0.01%
27,982
– –
CTRA
654
DELISTED
Coterra Energy
CTRA
$1.09M 0.01%
44,256
-248
-0.6% -$6.84K
PRLD icon
655
Prelude Therapeutics
PRLD
$375M
$1.09M 0.01%
179,850
+54,231
+43% +$348K
MLM icon
656
Martin Marietta Materials
MLM
$34.2B
$1.08M 0.01%
3,192
-4,371
-58% -$1.49M
NTR icon
657
Nutrien
NTR
$33.9B
$1.08M 0.01%
14,749
-91
-0.6% -$7.19K
FANG icon
658
Diamondback Energy
FANG
$56B
$1.06M 0.01%
7,767
-475
-6% -$69.4K
BLKB icon
659
Blackbaud
BLKB
$1.94B
$1.06M 0.01%
17,941
– –
MCHP icon
660
Microchip Technology
MCHP
$38.8B
$1.05M 0.01%
14,913
-6,482
-30% -$446K
NOMD icon
661
Nomad Foods
NOMD
$1.77B
$1.05M 0.01%
60,692
-55,665
-48% -$882K
PRVB
662
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$1.03M 0.01%
97,509
-110,142
-53% -$889K
GS icon
663
Goldman Sachs
GS
$289B
$1.03M 0.01%
2,989
+31
+1% +$10.8K
RBLX icon
664
Roblox
RBLX
$35.9B
$1.03M 0.01%
36,028
-10,291
-22% -$361K
ANGO icon
665
AngioDynamics
ANGO
$605M
$1.01M 0.01%
73,393
+27,182
+59% +$378K
DAY
666
DELISTED
Dayforce
DAY
$1M 0.01%
15,607
-3,865
-20% -$243K
GTM
667
ZoomInfo Technologies
GTM
$1.03B
$1M 0.01%
33,226
-220,940
-87% -$7.63M
ALLK
668
DELISTED
Allakos
ALLK
$989K 0.01%
117,448
-90,652
-44% -$630K
PVLA
669
Palvella Therapeutics
PVLA
$2.05B
$979K 0.01%
11,773
-1,500
-11% -$121K
RCKT icon
670
Rocket Pharmaceuticals
RCKT
$343M
$978K 0.01%
+50,000
New +$921K
LBRDK icon
671
Liberty Broadband Class C
LBRDK
$4.89B
$973K 0.01%
12,758
-9,046
-41% -$736K
RYTM icon
672
Rhythm Pharmaceuticals
RYTM
$7.31B
$946K 0.01%
32,479
-5,755
-15% -$148K
ZYME icon
673
Zymeworks
ZYME
$1.62B
$946K 0.01%
+120,305
New +$845K
LVS icon
674
Las Vegas Sands
LVS
$32.2B
$945K 0.01%
19,662
+3,172
+19% +$135K
SEM
675
DELISTED
Select Medical
SEM
$942K 0.01%
70,402
-759
-1% -$9.81K
25 26
27
28 29

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.